Kissei Pharmaceutical Co., Ltd.
4547.T · JPX
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | ¥11,961,000 | ¥11,161,000 | ¥13,680,000 | ¥16,507,000 |
| Dep. & Amort. | ¥4,615,000 | ¥4,254,000 | ¥4,109,000 | ¥3,730,000 |
| Deferred Tax | ¥0 | ¥0 | ¥0 | ¥0 |
| Stock-Based Comp. | ¥0 | ¥0 | ¥0 | ¥0 |
| Change in WC | -¥668,000 | -¥9,296,000 | -¥5,500,000 | ¥116,000 |
| Other Non-Cash | -¥9,387,000 | -¥7,796,000 | -¥18,968,000 | -¥18,820,000 |
| Operating Cash Flow | ¥6,521,000 | -¥1,677,000 | -¥6,679,000 | ¥1,533,000 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -¥8,565,000 | -¥1,201,000 | -¥2,547,000 | -¥1,919,000 |
| Net Acquisitions | ¥519,000 | ¥175,000 | -¥363,000 | -¥385,000 |
| Inv. Purchases | -¥978,000 | -¥2,400,000 | -¥1,866,000 | -¥5,757,000 |
| Inv. Sales/Matur. | ¥14,069,000 | ¥14,813,000 | ¥14,985,000 | ¥22,245,000 |
| Other Inv. Act. | -¥93,000 | -¥2,697,000 | -¥4,208,000 | -¥3,408,000 |
| Investing Cash Flow | ¥4,952,000 | ¥8,690,000 | ¥6,001,000 | ¥10,776,000 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -¥230,000 | -¥150,000 | -¥150,000 | -¥103,000 |
| Stock Issued | ¥0 | ¥0 | ¥0 | ¥0 |
| Stock Repurch. | -¥5,293,000 | -¥6,000,000 | ¥0 | ¥0 |
| Dividends Paid | -¥3,801,000 | -¥3,722,000 | -¥3,135,000 | -¥2,536,000 |
| Other Fin. Act. | -¥1,000 | -¥134,000 | -¥135,000 | -¥117,000 |
| Financing Cash Flow | -¥9,325,000 | -¥10,006,000 | -¥3,420,000 | -¥2,756,000 |
| Forex Effect | ¥27,000 | -¥3,000 | -¥21,000 | ¥4,000 |
| Net Chg. in Cash | ¥2,271,000 | -¥2,997,000 | -¥4,120,000 | ¥9,557,000 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | ¥45,887,000 | ¥48,884,000 | ¥53,004,000 | ¥43,447,000 |
| End Cash | ¥48,158,000 | ¥45,887,000 | ¥48,884,000 | ¥53,004,000 |
| Free Cash Flow | ¥2,014,000 | -¥3,510,000 | -¥9,226,000 | -¥386,000 |